EveryONE Medicines logo — EveryONE Medicines delivers individualized precision therape...

EveryONE Medicines

EveryONE Medicines delivers individualized precision therapeutics customized to the unique genetic mutation of patients.

Founded 2020 United States Boston, United States 9 employees Biotechnology, Health and Wellness

General Information

Company Name EveryONE Medicines
Founded Year 2020
Location United States Boston, United States +1
Employees 9
Industries Biotechnology, Health and Wellness
Social

Get notified when EveryONE Medicines moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EveryONE Medicines

EveryONE Medicines is a biotechnology startup founded in 2020, dedicated to developing individualized precision medicines customized to the unique genetic mutation of patients. With the slogan "EveryONE Medicines delivers individualized precision therapeutics customized to the unique genetic mutation of patients," the company aims to target genetic variants causing fatal, neurodegenerative diseases unique to just a few or even ONE patient. The momentum is growing as technological advances with genomic testing and the prevalence of testing is rapidly improving to identify the rarest of rare mutations. Through a collaborative effort across all stakeholders in the treatment and diagnosis of rare genetic disease, EveryONE Medicines is working to bring a scalable solution to meet the needs of individual patients who currently have limited hope. While specific details about the headquarters, last investment, and investors aren't available, the commitment of EveryONE Medicines to address rare genetic diseases through individualized precision medicines presents an intriguing opportunity for investors who are interested in the biotechnology and health and wellness industries.

Taxonomy: Precision Medicine, Genomic Testing, Rare Genetic Diseases, Individualized Therapeutics, Neurodegenerative Diseases, Genetic Variants, Collaborative Healthcare, Scalable Solutions, Rare Mutation Identification, Personalized Medicine

No funding data available for EveryONE Medicines yet.

Get notified when EveryONE Medicines raises funding

EveryONE Medicines Alternatives & Competitors

EveryONE Medicines vs

Autifony are dedicated to developing new medicines to treat rare genetic CNS disorders

Series Unknown
37 employees
Biotechnology, Health and Wellness
EveryONE Medicines vs
Locanabio, Inc.
Locanabio, Inc. United States

Creating RNA-targeting gene therapies to treat devastating diseases

Series B
7 employees
Biotechnology, Health Care
EveryONE Medicines vs
Neurogene Inc.
Neurogene Inc. United States

Reimagining the future for rare neurological diseases

Unknown
130 employees
Biotechnology

FAQ About EveryONE Medicines

EveryONE Medicines delivers individualized precision therapeutics customized to the unique genetic mutation of patients.
EveryONE Medicines was founded in 2020.
EveryONE Medicines is headquartered in Boston, United States.
EveryONE Medicines operates in the following industries: Biotechnology, Health and Wellness.
EveryONE Medicines has approximately 9 employees.
Top alternatives and competitors to EveryONE Medicines include Autifony Therapeutics, Locanabio, Inc., Neurogene Inc., Homology Medicines, Gene Cradle. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EveryONE Medicines and Autifony Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EveryONE Medicines and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy